Forex largely explains the admin/corp cost increase, it was positive in Q3 and full year roughly matches last year. Sales were down as all the pent up China demand occurred in Q3 and has since returned to normal/disrupted and globally Covid is disrupting distribution improvements. In the webinar Rob said the inventory spend was for Q1 manufacturing. He didn't go into general manufacturing timing.
They typically don't keep significant finished product on hand. Q2 manufacturing spending lifted in preparation for NMPA approval but in that case they had significant orders waiting. Given they were sitting on 500K in raw material start of FY19/20 and almost no WIP/FP I don't know why 123K extra was worth highlighting especially since they would've run it down significantly. The annual report may give a better idea.
- Forums
- ASX - By Stock
- UCM
- Ann: Appendix 4C - quarterly
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: Appendix 4C - quarterly, page-54
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 132270 | 0.012 |
1 | 100000 | 0.010 |
1 | 150000 | 0.008 |
2 | 2000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online